Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Folgerdiena M de Vries

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Deutsches Arzteblatt International|September 25, 2024
In ReplyFolgerdiena M de Vries
British Journal of Clinical Pharmacology|November 24, 2020
Polypharmacy, potentially inappropriate medication and pharmacogenomics drug exposure in the Rhineland StudyFolgerdiena M de Vries, Julia C Stingl, Monique M B Breteler
Plos One|November 6, 2014
Efficacy of standard and intensive statin treatment for the secondary prevention of cardiovascular and cerebrovascular events in diabetes patients: a meta-analysisFolgerdiena M de Vries, Johan Kolthof, Maarten J Postma, et al.
British Journal of Clinical Pharmacology|December 15, 2021
Validation of self-reported medication use applying untargeted mass spectrometry-based metabolomics techniques in the Rhineland studyNersi Alaeddin, Julia C Stingl, Monique M B Breteler, et al.
Drugs|November 29, 2012
Primary prevention of major cardiovascular and cerebrovascular events with statins in diabetic patients: a meta-analysisFolgerdiena M de Vries, Petra Denig, Koen B Pouwels, et al.
European Journal of Preventive Cardiology|August 25, 2023
Prevalence and determinants of over- and undertreatment among users of antihypertensive drugs in the general population: The Rhineland StudyNersi Alaeddin, Gökhan Pehlivan, Julia C Stingl, et al.
Scientific Reports|December 16, 2024
The impact of proton pump inhibitors on brain health based on cross-sectional findings from the Rhineland StudyNersi Alaeddin, Alexandra Koch, Rika Etteldorf, et al.
Journal of Clinical Epidemiology|December 16, 2014
Birth cohort appeared to confound effect estimates of guideline changes on statin utilizationMaarten J Bijlsma, Fanny Janssen, René Lub, et al.
Plos One|October 8, 2015
The Role of Patients' Age on Their Preferences for Choosing Additional Blood Pressure-Lowering Drugs: A Discrete Choice Experiment in Patients with DiabetesSieta T de Vries, Folgerdiena M de Vries, Thijs Dekker, et al.
Deutsches Arzteblatt International|September 1, 2023
Over- and Undertreatment With LevothyroxineNersi Alaeddin, Rutchanna M S Jongejan, Julia C Stingl, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Deutsches Arzteblatt International|September 25, 2024
In ReplyFolgerdiena M de Vries
British Journal of Clinical Pharmacology|November 24, 2020
Polypharmacy, potentially inappropriate medication and pharmacogenomics drug exposure in the Rhineland StudyFolgerdiena M de Vries, Julia C Stingl, Monique M B Breteler
Plos One|November 6, 2014
Efficacy of standard and intensive statin treatment for the secondary prevention of cardiovascular and cerebrovascular events in diabetes patients: a meta-analysisFolgerdiena M de Vries, Johan Kolthof, Maarten J Postma, et al.
British Journal of Clinical Pharmacology|December 15, 2021
Validation of self-reported medication use applying untargeted mass spectrometry-based metabolomics techniques in the Rhineland studyNersi Alaeddin, Julia C Stingl, Monique M B Breteler, et al.
Drugs|November 29, 2012
Primary prevention of major cardiovascular and cerebrovascular events with statins in diabetic patients: a meta-analysisFolgerdiena M de Vries, Petra Denig, Koen B Pouwels, et al.
European Journal of Preventive Cardiology|August 25, 2023
Prevalence and determinants of over- and undertreatment among users of antihypertensive drugs in the general population: The Rhineland StudyNersi Alaeddin, Gökhan Pehlivan, Julia C Stingl, et al.
Scientific Reports|December 16, 2024
The impact of proton pump inhibitors on brain health based on cross-sectional findings from the Rhineland StudyNersi Alaeddin, Alexandra Koch, Rika Etteldorf, et al.
Journal of Clinical Epidemiology|December 16, 2014
Birth cohort appeared to confound effect estimates of guideline changes on statin utilizationMaarten J Bijlsma, Fanny Janssen, René Lub, et al.
Plos One|October 8, 2015
The Role of Patients' Age on Their Preferences for Choosing Additional Blood Pressure-Lowering Drugs: A Discrete Choice Experiment in Patients with DiabetesSieta T de Vries, Folgerdiena M de Vries, Thijs Dekker, et al.
Deutsches Arzteblatt International|September 1, 2023
Over- and Undertreatment With LevothyroxineNersi Alaeddin, Rutchanna M S Jongejan, Julia C Stingl, et al.
Pageof 2